PDZ and LIM Domain 2 (PDLIM2) (C-Term) Peptide
PDLIM2
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5510834
Quick Overview for PDZ and LIM Domain 2 (PDLIM2) (C-Term) Peptide (ABIN5510834)
Target
PDLIM2
(PDZ and LIM Domain 2 (PDLIM2))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- VLVLPPSPGP RSSRPSMDSE GGSLLLDEDS EVFKMLQENR EGRAAPRQSS
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-PDLI2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PDLIM2 (PDZ and LIM Domain 2 (PDLIM2))
-
Background
-
This gene encodes a member of the ALP subfamily of PDZ-LIM domain proteins. The encoded protein suppresses anchorage-dependent growth and promotes cell migration and adhesion through interactions with the actin cytoskeleton via the PDZ domain. The encoded protein is also a putative tumor suppressor protein, and decreased expression of this gene is associated with several malignancies including breast cancer and adult T-cell leukemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
Alias Symbols: PDLIM2,PP6345,
Protein Size: 278 -
Gene ID
- 64236
-
NCBI Accession
- NP_932159
Target
-
You are here:
